News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
869,805 Results
Type
Article (87955)
Company Profile (826)
Press Release (781007)
Multimedia
Podcasts (194)
Webinars (28)
Section
Business (233259)
Career Advice (4146)
Deals (39877)
Drug Delivery (150)
Drug Development (91414)
Employer Resources (204)
FDA (18385)
Job Trends (17426)
News (397905)
Policy (39969)
Tag
Academia (3010)
Academic (2)
Accelerated approval (34)
Adcomms (36)
Allergies (145)
Alliances (56981)
ALS (180)
Alzheimer's disease (1787)
Antibody-drug conjugate (ADC) (345)
Approvals (18559)
Artificial intelligence (621)
Autoimmune disease (156)
Automation (35)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (200)
Biotechnology (491)
Bladder cancer (162)
Brain cancer (65)
Breast cancer (655)
Cancer (4993)
Cardiovascular disease (438)
Career advice (3569)
Career pathing (41)
CAR-T (302)
CDC (59)
Celiac Disease (1)
Cell therapy (821)
Cervical cancer (37)
Clinical research (76970)
Collaboration (1785)
Company closure (5)
Compensation (1147)
Complete response letters (70)
COVID-19 (2991)
CRISPR (98)
C-suite (844)
Cystic fibrosis (154)
Data (6207)
Decentralized trials (2)
Denatured (71)
Depression (150)
Diabetes (530)
Diagnostics (7218)
Digital health (44)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (299)
Drug pricing (222)
Drug shortages (36)
Duchenne muscular dystrophy (238)
Earnings (100091)
Editorial (63)
Employer branding (25)
Employer resources (173)
Events (135030)
Executive appointments (1030)
FDA (21525)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1543)
Gene editing (212)
Generative AI (63)
Gene therapy (665)
GLP-1 (1118)
Government (5437)
Grass and pollen (8)
Guidances (385)
Healthcare (20943)
HIV (60)
Huntington's disease (48)
IgA nephropathy (86)
Immunology and inflammation (289)
Immuno-oncology (57)
Indications (88)
Infectious disease (3277)
Inflammatory bowel disease (205)
Inflation Reduction Act (17)
Influenza (119)
Intellectual property (243)
Interviews (816)
IPO (17954)
IRA (60)
Job creations (5199)
Job search strategy (2866)
JPM (65)
Kidney cancer (17)
Labor market (91)
Layoffs (659)
Leadership (40)
Legal (10160)
Liver cancer (98)
Longevity (14)
Lung cancer (676)
Lymphoma (375)
Machine learning (45)
Management (66)
Manufacturing (836)
MASH (172)
Medical device (15016)
Medtech (15064)
Mergers & acquisitions (22975)
Metabolic disorders (1384)
Multiple sclerosis (161)
NASH (23)
Neurodegenerative disease (351)
Neuropsychiatric disorders (96)
Neuroscience (3095)
Neurotech (1)
NextGen: Class of 2026 (7707)
Non-profit (5110)
Now hiring (64)
Obesity (669)
Opinion (334)
Ovarian cancer (166)
Pain (204)
Pancreatic cancer (230)
Parkinson's disease (295)
Partnered (39)
Patents (498)
Patient recruitment (470)
Peanut (60)
People (66868)
Pharmaceutical (145)
Pharmacy benefit managers (32)
Phase I (23788)
Phase II (33397)
Phase III (25171)
Pipeline (4884)
Policy (333)
Postmarket research (3554)
Preclinical (10690)
Press Release (72)
Prostate cancer (242)
Psychedelics (53)
Radiopharmaceuticals (298)
Rare diseases (884)
Real estate (7439)
Recruiting (80)
Regulatory (28956)
Reports (66)
Research institute (2722)
Resumes & cover letters (651)
Rett syndrome (27)
RNA editing (20)
RSV (83)
Schizophrenia (158)
Series A (256)
Series B (195)
Service/supplier (30)
Sickle cell disease (103)
Special edition (27)
Spinal muscular atrophy (176)
Sponsored (48)
Startups (4333)
State (2)
Stomach cancer (20)
Supply chain (112)
Tariffs (99)
The Weekly (121)
Vaccines (1140)
Venture capital (94)
Weight loss (460)
Women's health (85)
Worklife (21)
Date
Today (106)
Last 7 days (434)
Last 30 days (2219)
Last 365 days (33022)
2026 (2116)
2025 (33228)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (88)
Alaska (7)
Arizona (340)
Arkansas (14)
Asia (51530)
Australia (9045)
California (11456)
Canada (3292)
China (1152)
Colorado (485)
Connecticut (497)
Delaware (343)
Europe (118389)
Florida (1673)
Georgia (368)
Hawaii (4)
Idaho (68)
Illinois (956)
India (66)
Indiana (540)
Iowa (24)
Japan (420)
Kansas (133)
Kentucky (42)
Louisiana (29)
Maine (83)
Maryland (1449)
Massachusetts (8441)
Michigan (354)
Minnesota (662)
Mississippi (6)
Missouri (139)
Montana (35)
Nebraska (29)
Nevada (126)
New Hampshire (85)
New Jersey (3080)
New Mexico (33)
New York (3029)
North Carolina (1602)
North Dakota (10)
Northern California (5467)
Ohio (350)
Oklahoma (22)
Oregon (54)
Pennsylvania (2291)
Puerto Rico (21)
Rhode Island (50)
South America (1661)
South Carolina (64)
South Dakota (1)
Southern California (4424)
Tennessee (175)
Texas (1807)
United States (41345)
Utah (343)
Vermont (1)
Virginia (288)
Washington D.C. (87)
Washington State (960)
West Virginia (4)
Wisconsin (125)
Wyoming (2)
There are 869,805 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
GLP-1
Roche’s 22% Weight Loss Benefit Seals GLP-1’s Phase III Plans, Boosts Zealand Combo
Roche said the Phase II results help build the case for advancing CT-388 into late-stage testing, which is set to get underway this quarter.
January 27, 2026
·
2 min read
·
Annalee Armstrong
Inflammatory bowel disease
Boehringer Commits Up to $1.26B in IBD Pact With China’s Simcere
The cornerstone of the deal is SIM0709, which Simcere designed to target both TL1A and IL-23, crucial players in facilitating inflammation. Boehringer Ingelheim will advance the asset for inflammatory bowel diseases.
January 27, 2026
·
2 min read
·
Tristan Manalac
GLP-1
Baseline Debuts to Challenge GLP-1 Giant Lilly in Alcohol Use Disorder
While Baseline Therapeutics declined to disclose its starting capital, the startup said it will use the funds to push its GLP-1 asset BT-001 into late-stage development, with two trials planned this year.
January 27, 2026
·
2 min read
·
Tristan Manalac
Legal
CytoDyn’s Former CEO Gets Jail Time, $5.3M+ Fine for Securities Fraud
Nader Pourhassan, who led CytoDyn for nearly 10 years, was convicted in December 2024 of misleading investors regarding the biotech’s investigational COVID-19 and HIV drug, which artificially inflated its share price.
January 27, 2026
·
2 min read
·
Tristan Manalac
Press Releases
ICON’s Accellacare Site Network Expands Oncology Research Capabilities With New Cancer Institute Partnership
January 27, 2026
·
3 min read
Press Releases
NeoGenomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026
January 27, 2026
·
1 min read
Press Releases
TRexBio Closes $50 Million Financing to Support a Growing Clinical-Stage Immunology Pipeline of Tissue-Targeted Treg Therapeutics
January 27, 2026
·
4 min read
Press Releases
Integrated Biosciences Appoints Daniel J. Anderson, Ph.D. as Chief Scientific Officer
January 27, 2026
·
2 min read
Press Releases
Bial Achieves Key Milestone in Phase 2b ACTIVATE Study of BIA 28-6156 in GBA1-Associated Parkinson’s Disease
January 27, 2026
·
4 min read
Press Releases
Tubulis Adds Steve Kelsey as Independent Director to its Advisory Board
January 27, 2026
·
3 min read
1 of 86,981
Next
